FLT3 and acute myeloid leukemia: A retrospective study showed that a greater proportion of monocytes (>40%) and elevated LDH and WBC (approximately 40 × 109/L) were strong risk factors for CSF AML, as were patients with core binding factor and FLT3 mutations (5).